News

Amgen has presented data from a phase 3, head-to-head trial of Denosumab versus Zometa (zoledronic acid) in the treatment of bone metastases in 2,046 patients with advanced breast

Zentiva, a Czech pharmaceutical company, will start manufacturing generic version of Pfizer’s Viagra. The production will begin in 2010. The company will engage manufacturing site at Slovak town

Gilead Sciences has reported that FDA’s Anti-Infective Drugs Advisory Committee has recommended aztreonam for inhalation solution to be approved for the treatment of infections due to Pseudomonas aeruginosa

YM BioSciences has presented the first results of a collaborative program between the company and the National Research Council of Canada’s Biotechnology Research Institute (NRC-BRI). Utilising YM’s IntelliMab

Delta Industrial will be featuring its new web converting system at ATX West 2010. Demonstration of the Delta Mod-Tech in Booth 4325 will include in-line rotary die-cutting and

Biomatrica has launched DNAgard, a room temperature-based liquid formulation for stabilisation and storage of tissues and cells. The new DNAgard product is solutions for room-temperature storage, archiving, stabilisation

Mylan has reported that its subsidiary, Mylan Pharmaceuticals has received final approval from the FDA for its Abbreviated New Drug Application (ANDA) for Levetiracetam tablets, 1000mg. Levetiracetam tablets

GlaxoSmithKline (GSK) has reported Phase III study results which showed that women with an aggressive form of breast cancer experienced a median survival of 14 months, when treated

UPMC Health Plan (UPMC) has signed an agreement to offer free brain fitness software from Posit Science to all UPMC for Life Medicare Advantage members. This brain training